4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide

C30H31F3N8O — CID 11421820

IUPAC4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide
SMILESCCc1cc(C(F)(F)F)cc2c1n(C)/c(=N\c1ccc(C(C)(C)C)cc1)n2Cc1ccc(C(=O)Nc2nn[nH]n2)cc1
InChIInChI=1S/C30H31F3N8O/c1-6-19-15-22(30(31,32)33)16-24-25(19)40(5)28(34-23-13-11-21(12-14-23)29(2,3)4)41(24)17-18-7-9-20(10-8-18)26(42)35-27-36-38-39-37-27/h7-16H,6,17H2,1-5H3,(H2,35,36,37,38,39,42)/b34-28+
InChIKeyHSTGPLBUAKBMNV-CDSHQWRTSA-N
MW576.63 g/mol
LogP5.90
Rot. Bonds6

About 4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide

4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide (PubChem CID 11421820) has the molecular formula C30H31F3N8O and a molecular weight of 576.63 g/mol. Its IUPAC name is 4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide.

Molecular Properties

Compound Name4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide
PubChem CID11421820
Molecular FormulaC30H31F3N8O
Molecular Weight576.63 g/mol
Exact Mass576.26
IUPAC Name4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide
SMILESCCc1cc(C(F)(F)F)cc2c1n(C)/c(=N\c1ccc(C(C)(C)C)cc1)n2Cc1ccc(C(=O)Nc2nn[nH]n2)cc1
InChIInChI=1S/C30H31F3N8O/c1-6-19-15-22(30(31,32)33)16-24-25(19)40(5)28(34-23-13-11-21(12-14-23)29(2,3)4)41(24)17-18-7-9-20(10-8-18)26(42)35-27-36-38-39-37-27/h7-16H,6,17H2,1-5H3,(H2,35,36,37,38,39,42)/b34-28+
InChIKeyHSTGPLBUAKBMNV-CDSHQWRTSA-N
XLogP5.90
TPSA105.78 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms42
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500576.63
LogP ≤ 55.90
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze 4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-[[4-ethyl-2-(4-fluorophenyl)imino-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide
CID 11387112
4-[8-tert-Butyl-3-(4-fluoro-phenyl)-2-oxo-1,3-diaza-spiro[4.5]dec-1-ylmethyl]-N-(2H-tetrazol-5-yl)-benzamide
CID 44404222
4-[8-tert-Butyl-2-oxo-3-(4-trifluoromethyl-phenyl)-1,3-diaza-spiro[4.5]dec-1-ylmethyl]-N-(2H-tetrazol-5-yl)-benzamide
CID 44404227
4-(8-tert-Butyl-2-oxo-3-p-tolyl-1,3-diaza-spiro[4.5]dec-1-ylmethyl)-N-(2H-tetrazol-5-yl)-benzamide
CID 44404234
4-[8-tert-Butyl-3-(3,4-difluoro-phenyl)-2-oxo-1,3-diaza-spiro[4.5]dec-1-ylmethyl]-N-(2H-tetrazol-5-yl)-benzamide
CID 10459436
4-[[4-ethyl-3-methyl-2-(4-methylphenyl)imino-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide
CID 11180162
(3S)-3-(benzylcarbamoylamino)-N-(2H-tetrazol-5-yl)-1-[3-(trifluoromethyl)benzoyl]-2H-indole-3-carboxamide
CID 164513465
4-[[8-tert-butyl-3-(2,4-difluorophenyl)-2-oxo-1,3-diazaspiro[4.5]decan-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide
CID 10052485
4-[[[3,5-bis(trifluoromethyl)phenyl]carbamoyl-(4-tert-butylcyclohexyl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide
CID 10100286
4-[[8-tert-butyl-3-[3-fluoro-5-(trifluoromethyl)phenyl]-2-oxo-1,3-diazaspiro[4.5]decan-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide
CID 10415706
4-[[2-[4-(3,4-dimethylcyclopentyl)phenyl]imino-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide
CID 11204091
4-[[2-(4-tert-butylphenyl)imino-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide
CID 11238141

Frequently Asked Questions

What is the IUPAC name of 4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide?
The IUPAC name of 4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide (CID 11421820) is 4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide.
What is the SMILES notation for 4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide?
The canonical SMILES for 4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide is CCc1cc(C(F)(F)F)cc2c1n(C)/c(=N\c1ccc(C(C)(C)C)cc1)n2Cc1ccc(C(=O)Nc2nn[nH]n2)cc1.
What is the InChIKey of 4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide?
The InChIKey is HSTGPLBUAKBMNV-CDSHQWRTSA-N. The full InChI is InChI=1S/C30H31F3N8O/c1-6-19-15-22(30(31,32)33)16-24-25(19)40(5)28(34-23-13-11-21(12-14-23)29(2,3)4)41(24)17-18-7-9-20(10-8-18)26(42)35-27-36-38-39-37-27/h7-16H,6,17H2,1-5H3,(H2,35,36,37,38,39,42)/b34-28+.
What are the key properties of 4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide?
4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide has a molecular weight of 576.63 g/mol, XLogP of 5.90, 6 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[2-(4-tert-butylphenyl)imino-4-ethyl-3-methyl-6-(trifluoromethyl)benzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide is sourced from PubChem (CID 11421820), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).